trial · primary record
buntanetap/posiphen
Parkinson's Disease (PD)
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 500 |
| Primary completion | 2029-11 |
| Primary endpoint | Safety of buntanetap |
| Registry ID | NCT07284784 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:28.126Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07284784
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.